These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4004 related articles for article (PubMed ID: 8687112)

  • 41. Effective tumor targeting: strategies for the delivery of Armed Antibodies.
    MacDonald GC; Glover N
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):177-83. PubMed ID: 15782542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunologic advances in monoclonal antibody therapy: implications for oncology nursing.
    Karius D; Marriott MA
    Oncol Nurs Forum; 1997 Apr; 24(3):483-94; QUIZ 495-6. PubMed ID: 9127361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal antibodies in cancer immunotherapy.
    Reisfeld RA
    Clin Lab Med; 1992 Jun; 12(2):201-16. PubMed ID: 1611818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
    Weiner LM; Clark JI; Davey M; Li WS; Garcia de Palazzo I; Ring DB; Alpaugh RK
    Cancer Res; 1995 Oct; 55(20):4586-93. PubMed ID: 7553634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
    Ceriani RL; Blank EW
    Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential].
    Mach JP; Pèlegrin A; Folli S; Buchegger F
    Bull Acad Natl Med; 1992 Jun; 176(6):879-89. PubMed ID: 1464034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization.
    Payne WJ; Coggin JH
    J Natl Cancer Inst; 1985 Sep; 75(3):527-44. PubMed ID: 2411994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antibody treatment for cancer].
    Sasaki S; Ozeki I; Takekawa M; Tsujisaki M; Imai K
    Nihon Geka Gakkai Zasshi; 2000 Sep; 101(9):607-11. PubMed ID: 11022675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Targeting therapy using monoclonal antibody directed against growth factor receptors].
    Jinno H; Ueda M; Enomoto K; Ikeda T; Kitajima M
    Hum Cell; 1993 Sep; 6(3):188-93. PubMed ID: 8297815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of anti-idiotype monoclonal antibodies for Sialyl Le(a) antigen.
    Furuya A; Yoshida H; Hanai N
    Anticancer Res; 1992; 12(1):27-31. PubMed ID: 1567176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of malignant melanoma with monoclonal antibodies.
    Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
    Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
    Castello G; D'Alessio V
    Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
    Pimm MV
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical status of monoclonal antibodies in the treatment of colorectal carcinoma.
    Mellstedt H; Frodin JE; Masucci G
    Oncology (Williston Park); 1989 Dec; 3(12):25-32; discussion 37-9, 42. PubMed ID: 2701408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.
    Weltman JK; Pedroso P; Johnson SA; Davignon D; Fast LD; Leone LA
    Cancer Res; 1987 Nov; 47(21):5552-6. PubMed ID: 2822229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 201.